Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
Status:
Recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The investigators propose to evaluate the efficacy of the combination of standard
chemotherapy with bevacizumab with Pembrolizumab in women with recurrent, persistent, or
metastatic cervical cancer.